Position in LH
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$10,775,520
+$480,123 QoQ
Shares Held
38,484
-0.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#162
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cardinal Capital Management holds $32,347,065 across 5 Diagnostics & Research names. LH ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
This page
|
38,484 | $10,775,520 | |
| 2 | A |
Agilent Technologies, Inc.
|
75,200 | $9,988,816 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
14,151 | $7,449,652 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
11,206 | $2,541,408 | |
| 5 | WAT |
Waters Corp /De/
|
4,244 | $1,591,669 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,775,520 | 38,484 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $10,295,397 | 38,587 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $9,634,042 | 38,401 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $10,911,724 | 38,012 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $9,932,853 | 37,838 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $8,538,997 | 36,689 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $8,261,253 | 36,025 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $7,664,023 | 34,294 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $6,894,918 | 33,880 | Shares | Sole | 2024-07-12 | |
| No filing history on record for this holder in this stock. | ||||||